China Medicines: Pfizer is a prescription drug whose sales volume cannot be estimated and has been included in the temporary medical insurance

Share to WeChat Open WeChat, click “Discovery” at the bottom, Use “scan” to share the webpage to Moments.

China Business News 2022-12-20 15:50:23

Editor in charge: Zhu Mengyun

Today the reporter called China Medicines as an investor. The company stated that Pfizer’s new crown drug is a prescription drug, and the sales volume of the new contract cannot be predicted, and the company stated that the Pfizer’s new crown drug in the new contract will also be temporarily included in the payment of local medical insurance, and the specific situation will be implemented according to national policies.

China Medicines: Pfizer is a prescription drug whose sales volume cannot be estimated and has been included in the temporary medical insurance

Today the reporter called China Medicines as an investor. The company stated that Pfizer’s new crown drug is a prescription drug, and the sales volume of the new contract cannot be predicted, and the company stated that the Pfizer’s new crown drug in the new contract will also be temporarily included in the payment of local medical insurance, and the specific situation will be implemented according to national policies.

This content is original by China Business News, and the copyright belongs to China Business News. Without the written authorization of China Business News, it may not be used in any way, including reprinting, excerpting, duplicating or mirroring. Yicai reserves the right to pursue the legal responsibility of the infringer. For authorization, please contact the copyright department of Yicai: 021-22002972 or 021-22002335; [e-mail].